Complete Remission Rate， CRR
1 clinical trials · Condition
◉ Watch Complete Remission Rate， CRR
| Record | Firm | Date |
|---|---|---|
| Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma (NCT07542912) | Sun Yat-sen University | 2026-06-01 |
Track Complete Remission Rate， CRR automatically
Every clearance here is in the API, with alerts when new ones post.